Navigation Links
SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement

AUSTIN, Texas, Nov. 5 /PRNewswire/ -- SpineSmith Partners has signed an initial agreement with GenOsteo, Inc. to co-develop a unique scaffold that mimics the structure of natural cancellous bone. Following evaluation of several commercial products by SpineSmith's Research and Development Department, the company believes the GenOsteo scaffold represents a significant advancement in technology that creates a unique and ideal environment for the delivery of adult stem cells for skeletal repair and regeneration. Focused initially on developing fusion applications in conjunction with the use of SpineSmith interbody spinal spacers, SpineSmith believes that the proprietary GenOsteo process is unique and has the potential to provide an optimal cell carrier for several applications in spine, general orthopedics, trauma and plastic and reconstructive surgery.

Dr. James Poser, Vice President of Regenerative Medicine for SpineSmith, and his team will work closely with GenOsteo to bring this product to the market.

"GenOsteo has created an elegant and highly effective material that can be combined with adult stem cells for promoting bone formation. We look forward to collaborating with the scientists at GenOsteo to produce the next generation point-of-care adult stem cell product that will become the preferred fusion product of orthopedic and neurosurgeons," said Poser.

GenOsteo scientists developed the technology and have licensed the rights from the University of Texas at San Antonio. The GenOsteo process produces a calcium phosphate scaffold with uniform porosity, surface and resorption characteristics.

"GenOsteo is delighted to partner with SpineSmith to develop hydroxyapatite-based scaffold technology for optimal delivery of cell-based spinal implant therapies. It represents an ideal marriage of implant design, cell therapy and advanced material science," said Daniel Oh, president of GenOsteo and co-inventor of the technology.

Both companies will be attending the North American Spine Society (NASS) on November 11-14 in San Francisco. Members of the development team will be there to demonstrate and discuss how this unique scaffolding can revolutionize the presentation of cells in spinal fusion. SpineSmith and GenOsteo expect to bring this product to market in late 2010.

About GenOsteo

GenOsteo has developed a bone-like scaffold that is similar to the composition and structure of the inorganic portion of the natural cancellous bone. GenOsteo scaffolds allow the formation or regeneration of functional bone tissues and can be adapted to fit into implants such as with interbody spacers used in spinal fusion. In addition, bony defects resulting from trauma or disease in long bones can be regenerated to provide aesthetics as well as functional restoration by the use of the GenOsteo scaffolds.

About SpineSmith Partners, LP

SpineSmith Partners, LP is dedicated to creating better ways to facilitate and accelerate the healing of spinal disorders through integration of innovative medical devices and biologic technologies. SpineSmith designs, develops, and markets implants and biologics for surgical fixation, correction, and tissue regeneration of the spine. SpineSmith's dedication to a collaborative approach between scientists, engineers and spine surgeons results in the development of truly innovative biological and hardware technologies.

SOURCE SpineSmith Partners

SOURCE SpineSmith Partners
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SpineSmith Partners Collaborates with University of Texas Biomedical Engineering Students to Develop Innovative Products
2. Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health
3. Emerson Resources Forges Strategic Partnership with Bio Research
4. Public-Private Partnerships Key to Achieving Global Food Security, Says DuPont Leader
5. Diabetics: 3tailer Partners with MyGlucoHealth on World's 1st Blood Glucose Meter with Wireless Bluetooth for Diabetes
6. Professional Pricing Society Announces Educational Partnership with Vendavo -- "PPS Accepting Vendavo Pricing Knowledge Series Awards to Certified Pricing Professional Program"
7. SourceMedical's Therapy Software Partners with FOTO, the Leading Provider of Patient Outcome Surveys
8. Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners
9. Blue Marble Energy and Bionavitas Announce Partnership to Produce Industrial Biochemicals from Microalgae
10. Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition
11. Abidance Consulting Partners with the FBI
Post Your Comments:
(Date:6/27/2016)... GUELPH, ON , June 27, 2016 /PRNewswire/ - BIOREM ... it has been advised by its major shareholders, Clean ... LP, United States based venture ... common shares of Biorem (on a fully diluted, as ... for the disposition of their entire equity holdings in ...
(Date:6/27/2016)... ... , ... Parallel 6 , the leading software as a service (SaaS) ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication between ... Using the CONSULT module, patients and physicians can schedule a face to face virtual ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
Breaking Biology Technology:
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
Breaking Biology News(10 mins):